The burly, tracked vehicles that shuttled Marine grunts from ships to shore for more than five decades were retired from the service last week, making way for the Corps’ next-generation amphibious ...
California-based Azalea Therapeutics, a biotech promising to redefine precision genomic medicines in vivo, has announced its official launch and completion of $82 million in seed and Series A ...
The Marine Corps is pivoting back to the amphibious and fleet support roles that defined it during World War II. The US Marine Corps is moving on from the long-serving Assault Amphibious Vehicle (AAV) ...
Paris Margaritis, DPhil, is a professional with over 28 years of experience in AAV gene therapy for hemophilia. A key focus of his work has been treating hemophilia patients with inhibitors. He earned ...
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback